Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank17
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P17
Within normal range
vs 2Y Ago
-10x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
2025-10.81%+83.4%
2024-65.15%-6138.2%
20231.08%+114.5%
2022-7.42%-3.3%
2021-7.19%-99.0%
2020-3.61%-244.8%
2019-1.05%-